PORT VIEW SURGERY — All Prescriptions & Medications — Page 3
Practice Code: L82066 | SALTASH, PL12 4BU
Showing results 101-150 of 551
| Medication | Items (12m) ↓ | Quantity | Cost | vs National |
|---|---|---|---|---|
| Sildenafil (Erectile Dysfunction) | 327 | 2,960 | £420 | -35.1% ▼ |
| Solifenacin | 323 | 13.8K | £1.2K | -32.3% ▼ |
| Lisinopril | 321 | 18.1K | £405 | -70.7% ▼ |
| Carbomer 940/980 | 319 | 7,670 | £1.8K | +109.5% ▲ |
| Zopiclone | 318 | 8,395 | £335 | -42.6% ▼ |
| Lacidipine | 313 | 15.8K | £1.3K | +161.9% ▲ |
| Insulin aspart | 308 | 2,116 | £14.0K | -19.1% ▼ |
| Hydrocortisone | 303 | 10.6K | £1.7K | -32.4% ▼ |
| Prochlorperazine maleate | 297 | 17.6K | £1.0K | +46.9% ▲ |
| Lamotrigine | 290 | 22.8K | £9.7K | -50.9% ▼ |
| 285 | 29.9K | £2.3K | +31.8% ▲ | |
| Clarithromycin | 284 | 7,962 | £1.7K | +15.7% ▲ |
| Diltiazem hydrochloride | 281 | 12.2K | £2.7K | -8.5% ▼ |
| Levetiracetam | 279 | 31.0K | £2.7K | -39.1% ▼ |
| Thiamine hydrochloride | 277 | 14.0K | £377 | -47.5% ▼ |
| Sulfasalazine | 276 | 33.8K | £8.7K | +112.0% ▲ |
| Sacubitril/valsartan | 276 | 18.4K | £30.1K | +15.3% ▲ |
| Tiotropium bromide | 273 | 2,196 | £7.0K | -10.2% ▼ |
| Nifedipine | 271 | 15.7K | £2.0K | +44.6% ▲ |
| Eplerenone | 270 | 7,124 | £1.4K | +1.8% vs avg |
| Betamethasone valerate | 251 | 21.5K | £1.3K | -34.8% ▼ |
| 250 | 293 | £12.9K | -19.5% ▼ | |
| Empagliflozin | 250 | 9,576 | £11.9K | -60.1% ▼ |
| Sitagliptin | 244 | 10.6K | £645 | -37.4% ▼ |
| Olanzapine | 243 | 8,796 | £1.7K | -34.4% ▼ |
| Risedronate sodium | 242 | 1,300 | £340 | +99.5% ▲ |
| 242 | 254 | £1.5K | +2.4% ▲ | |
| Combined ethinylestradiol 30mcg | 238 | 22.7K | £1.5K | -14.3% ▼ |
| Lorazepam | 236 | 6,974 | £1.4K | +65.6% ▲ |
| Estriol | 236 | 4,512 | £2.1K | +10.9% ▲ |
| 236 | 29.5K | £1.4K | -50.3% ▼ | |
| Esomeprazole | 235 | 13.1K | £1.0K | -41.9% ▼ |
| Trazodone hydrochloride | 234 | 12.2K | £418 | +14.5% ▲ |
| Sodium valproate | 231 | 34.3K | £5.6K | -27.4% ▼ |
| Mirabegron | 230 | 9,247 | £8.5K | -42.7% ▼ |
| Nicorandil | 226 | 13.6K | £2.1K | +57.0% ▲ |
| Aciclovir | 226 | 14.8K | £652 | +51.9% ▲ |
| Diclofenac diethyl | 218 | 26.8K | £1.3K | -38.6% ▼ |
| Methylphenidate hydrochloride | 217 | 8,676 | £7.2K | -16.0% ▼ |
| Risperidone | 214 | 10.3K | £3.1K | -15.4% ▼ |
| Co-careldopa (Carbidopa/levodopa) | 214 | 18.3K | £1.0K | -5.3% ▼ |
| Quinine sulfate | 212 | 6,125 | £1.1K | -26.8% ▼ |
| Hyoscine butylbromide | 208 | 16.7K | £1.3K | -10.8% ▼ |
| Tadalafil | 207 | 4,276 | £1.0K | +21.7% ▲ |
| Clotrimazole | 207 | 8,260 | £472 | +113.6% ▲ |
| Linagliptin | 206 | 7,308 | £8.3K | -49.7% ▼ |
| Promethazine hydrochloride | 205 | 11.2K | £1.3K | -42.6% ▼ |
| Perindopril erbumine | 204 | 9,124 | £731 | -61.6% ▼ |
| Dulaglutide | 196 | 834 | £15.3K | +71.0% ▲ |
| Other multivitamin preparations | 193 | 6,225 | £2.1K | +11.7% ▲ |
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.